Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch
®
Checkpoint Inhibitor Response Test
EpiSwitch
®
COVID-19 Severity Test
EpiSwitch
®
Explorer Array Kit
EPISWITCH
®
ANALYTICAL PORTAL
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
Contact Us
Press release for GIS on OBD collaboration_BMRC approved
Home
Milestones
Genome Institute of Singapore (GIS) and Oxford Biodynamics Pte (OBD) have signed a major Collaboration Agreement to develop EpiSwitch™ technology for epigenetic stem cell differentiation.
Press release for GIS on OBD collaboration_BMRC approved
Press release for GIS on OBD collaboration_BMRC approved
Privacy Preference Center
Privacy Preferences
